Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10

Proteomics

Volumn 6, Issue 19, 2006, Pages 5183-5192

  Le Moguen, Karen ^a,d   Lincet, Hubert ^a   Deslandes, Edwige ^a   Hubert Roux, Marie ^b   Lange, Catherine ^b   Poulain, Laurent ^a   Gauduchon, Pascal ^a   Baudin, Bruno ^a,c  

^a Groupe Régional d'Etudes sur le Cancer   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d GRECAN   (France)

Author keywords

Cisplatin; Drug resistance; Ovarian cancer; Proteome; Tumour cell lines

Indexed keywords

ALDEHYDE DEHYDROGENASE; CISPLATIN; CYTOKERATIN 18; CYTOKERATIN 8;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEOME; PROTEOMICS;

EID: 33749680959     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200500925     Document Type: Article

References (65)

1. Agarwal, R., Kaye, S. B., Nat. Rev. Cancer 2003, 3, 502-516.
2. Balch, C., Huang, T. H., Brown, R., Nephew, K. P., Am. J. Obstet. Gynecol. 2004, 191, 1552-1572.
3. Fraser, M., Leung, B., Jahani-Asl, A., Yan, X. et al., Reprod. Biol. Endocrinol. 2003, 1, 66.
4. Wang, D., Lippard, S. J., Nat. Rev. Drug Discov. 2005, 4, 307-320.
5. Plebani, M., Clin. Chim. Acta 2005, 357, 113-122.
6. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Lancet 2002, 359, 572-577.
7. Yu, J. K., Zheng, S., Tang, Y., Li, L., J. Zhejiang Univ. Sci. B 2005, 6, 227-231.
8. Zhang, Z., Bast, R. C., Yu, Y., Li, J. et al., Cancer Res. 2004, 64, 5882-5890.
9. Jazaeri, A. A., Awtrey, C. S., Chandramouli, G. V., Chuang, Y. E. et al., Clin. Cancer Res. 2005, 11, 6300-6310.
10. Schwartz, D. R., Kardia, S. L., Shedden, K. A., Kuick, R. et al., Cancer Res. 2002, 62, 4722-4729.
11. Selvanayagam, Z. E., Cheung, T. H., Wei, N., Vittal, R. et al., Cancer Genet. Cytogenet. 2004, 154, 63-66.
12. Warrenfeltz, S., Pavlik, S., Datta, S., Kraemer, E. T. et al., Mol. Cancer 2004, 3, 27.
13. Alaiya, A. A., Franzen, B., Fujioka, K., Moberger, B. et al., Int. J. Cancer 1997, 73, 678-683.
14. Alaiya, A. A., Franzen, B., Hagman, A., Oysvik, B. et al., Int. J. Cancer 2002, 98, 895-899.
15. Bergman, A. C., Benjamin, T., Alaiya, A., Waltham, M. et al., Electrophoresis 2000, 21, 679-686.
16. Fajac, A., Da Silva, J., Ahomadegbe, J. C., Rateau, J. G. et al., Int. J. Cancer 1996, 68, 67-74.
17. Poulain, L., Lincet, H., Duigou, F., Deslandes, E. et al., Int. J. Cancer 1998, 78, 454-463.
18. Scudiero, D. A., Monks, A., Sausville, E. A., J. Natl. Cancer Inst. 1998, 90, 862.
19. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Anal. Chem. 1996, 68, 850-858.
20. Young, T., Mei, F., Liu, J., Bast, R. C. et al., Oncogene 2005, 24, 6174-6184.
21. Young, T. W., Mei, F. C., Yang, G., Thompson-Lanza, J. A. et al., Cancer Res. 2004, 64, 4577-4584.
22. Bruneel, A., Labas, V., Mailloux, A., Sharma, S. et al., Proteomics 2003, 3, 714-723.
23. Tomonaga, T., Matsushita, K., Yamaguchi, S., Oh-Ishi, M. et al., Clin. Cancer Res. 2004, 10, 2007-2014.
24. He, Q. Y., Cheung, Y. H., Leung, S. Y., Yuen, S. T. et al., Proteomics 2004, 4, 3276-3287.
25. Zhan, X., Desiderio, D. M., Proteomics 2003, 3, 699-713.
26. Marceau, N., Loranger, A., Gilbert, S., Daigle, N. et al., Biochem. Cell Biol. 2001, 79, 543-555.
27. Jolly, C., Morimoto, R. I., J. Natl. Cancer Inst. 2000, 92, 1564-1572.
28. Parcellier, A., Gurbuxani, S., Schmitt, E., Solary, E. et al., Biochem. Biophys. Res. Commun. 2003, 304, 505-512.
29. Soti, C., Csermely, P., Pathol. Oncol. Res. 1998, 4, 316-321.
30. Sreedhar, A. S., Csermely, P., Pharmacol. Ther. 2004, 101, 227-257.
31. Yamamoto, K., Okamoto, A., Isonishi, S., Ochiai, K. et al., Cancer Lett. 2001, 168, 173-181.
32. Gerke, V., Moss, S. E., Physiol. Rev. 2002, 82, 331-371.
33. Parekh, H. K., Simpkins, H., Cancer Res. 1995, 55, 5203-5206.
34. Oshima, R. G., Cell Death Differ. 2002, 9, 486-492.
35. Hembrough, T. A., Vasudevan, J., Allietta, M. M., Glass, W. F. et al., J. Cell Sci. 1995, 108, 1071-1082.
36. Schneiderman, D., Kim, J. M., Senterman, M., Tsang, B. K., Apoptosis 1999, 4, 271-281.
37. Abedini, M. R., Qiu, Q., Yan, X., Tsang, B. K., Oncogene 2004, 23, 6997-7004.
38. Mezzanzanica, D., Balladore, E., Turatti, F., Luison, E. et al., Clin. Cancer Res. 2004, 10, 5202-5214.
39. Caulin, C., Ware, C. F., Magin, T. M., Oshima, R. G., J. Cell Biol. 2000, 149, 17-22.
40. Gilbert, S., Loranger, A., Daigle, N., Marceau, N., J. Cell Biol. 2001, 154, 763-773.
41. Gilbert, S., Loranger, A., Marceau, N., Mol. Cell Biol. 2004, 24, 7072-7081.
42. Inada, H., Izawa, I., Nishizawa, M., Fujita, E. et al., J. Cell Biol. 2001, 155, 415-426.
43. Ku, N. O., Liao, J., Omary, M. B., EMBO J. 1998, 17, 1892-1906.
44. Li, D., Ueta, E., Kimura, T., Yamamoto, T. et al., Cancer Sci. 2004, 95, 644-650.
45. Schweyer, S., Soruri, A., Heintze, A., Radzun, H. J. et al., Int. J. Oncol. 2004, 25, 1671-1676.
46. Woiniak, A., Drewa, G., Wozniak, B., Schachtschabel, D. O. et al., Med. Sci. Monit. 2005, 11, BR22-BR29.
47. Lindahl, R., Crit. Rev. Biochem. Mol. Biol. 1992, 27, 283-335.
48. Vasiliou, V., Pappa, A., Petersen, D. R., Chem. Biol. Interact. 2000, 129, 1-19.
49. Canuto, R. A., Ferro, M., Muzio, G., Bassi, A. M. et al., Carcinogenesis 1994, 15, 1359-1364.
50. Canuto, R. A., Muzio, G., Salvo, R. A., Maggiora, M. et al., Chem. Biol. Interact. 2001, 130-132, 209-218.
51. Ohsawa, I., Nishimaki, K., Yasuda, C., Kamino, K. et al., J. Neurochem. 2003, 84, 1110-1117.
52. Yoon, K. A., Nakamura, Y., Arakawa, H., J. Hum. Genet. 2004, 49, 134-140.
53. Radin, A. I., Zhoa, X. L., Woo, T. H., Colvin, O. M. et al., Biochem. Pharmacol. 1991, 42, 1933-1939.
54. Tsukamoto, N., Chen, J., Yoshida, A., Blood Cells Mol. Dis. 1998, 24, 231-238.
55. Yoshida, A., Dave, V., Han, H., Scanlon, K. J., Adv. Exp. Med. Biol. 1993, 328, 63-72.
56. Huang, H. L., Fang, L. W., Lu, S. P., Chou, C. K. et al., Oncogene 2003, 22, 8168-8177.
57. Chen, Y. J., Yuan, C.C., Chow, K. C., Wang, P. H. et al., Gynecol. Oncol. 2005, 97, 110-117.
58. Deng, H. B., Parekh, H. K., Chow, K. C., Simpkins, H., J. Biol. Chem. 2002, 277, 15035-15043.
59. Deng, H. B., Adikari, M., Parekh, H. K., Simpkins, H., Cancer Chemother. Pharmacol. 2004, 54, 301-307.
60. Tanaka, T., Akatsuka, S., Ozeki, M., Shirase, T. et al., Oncogene 2004, 23, 3980-3989.
61. Wang, Y., Serfass, L., Roy, M. O., Wong, J. et al., Biochem. Biophys. Res. Commun. 2004, 314, 565-570.
62. Shi, T., Dong, F., Liou, L. S., Duan, Z. H. et al., Mol. Carcinog. 2004, 40, 47-61.
63. Han, E. K., Tahir, S. K., Cherian, S. P., Collins, N. et al., Br. J. Cancer 2000, 83, 83-88.
64. Xin, W., Rhodes, D. R., Ingold, C., Chinnaiyan, A. M. et al., Am. J. Pathol. 2003, 162, 255-261.
65. Stewart, J. J., White, J. T., Yan, X., Collins, S. et al., Mol. Cell. Proteomics 2006, 5, 433-443.